Frontlight ResearchEarly access
Coeliac disease trials in United States
10 of 17 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationImaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule
- Where
- Boston
- Age
- 16 years and over
- People
- 108
- Run by
- Massachusetts General Hospital
See details and how to joinNCT02202681 - No phaseTaking peopleGF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)
- Where
- Boston
- Age
- 2 years to 18 years
- People
- 120
- Run by
- Boston Children's Hospital
See details and how to joinNCT06356220 - Phase 1Taking peopleSimulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
- Where
- Cleveland
- Age
- 18 years and over
- People
- 5
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT07117032 - No phaseEnrolling by invitationImmune Responses to Gluten
- Where
- Aurora, Boston
- Age
- 2 years to 101 years
- People
- 400
- Run by
- Boston Children's Hospital
See details and how to joinNCT05209568 - Phase 2Taking peopleStudy of DONQ52 in Active Celiac Disease
- Where
- Akron, Anniston, Bellevue, Boston, Chandler, Clermont, Colorado Springs, Columbia, Denver, Escondido, Folsom, Gardena, Garland, Glenview, Gurnee, Harrisburg, Hermitage, Homewood, Jacksonville, Katy, Lancaster, Las Vegas, Litchfield, Lynchburg, Mentor, Metairie, Miami, Miami Lakes, Mobile, New Orleans, Norman, Ocala, Ogden, Palmetto Bay, Portland, Providence, Reno, Richmond, Rochester, Rockford, Saint Augustine, San Diego, Sandy City, Scottsdale, Stamford, St Louis, Sugar Land, Tampa, Tomball, Waco, West Jordan, Wichita Falls
- Age
- 18 years to 75 years
- People
- 92 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT07239336 - No phaseTaking peopleTissue Destruction and Healing in Celiac Disease
- Where
- Chicago, Pasadena, Rochester
- Age
- 18 years to 75 years
- People
- 220
- Run by
- University of Chicago
See details and how to joinNCT05680012 - Phase 1Taking peopleA First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
- Where
- Stanford
- Age
- 18 years and over
- People
- 20
- Run by
- Nielsen Fernandez-Becker
See details and how to joinNCT07377565 - No phaseTaking peopleGluten Technology and Education for Celiac Health
- Where
- Boston, Chicago, Nashville, New York
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Columbia University
See details and how to joinNCT06059716 - No phaseEnrolling by invitationBehavioral Intervention for Celiac Disease
- Where
- Washington D.C.
- Age
- 12 years to 16 years
- People
- 96
- Run by
- Children's National Research Institute
See details and how to joinNCT05204446 - No phaseTaking peopleEUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
- Where
- Orlando
- Age
- 18 years and over
- People
- 94
- Run by
- Orlando Health, Inc.
See details and how to joinNCT06178315